However, CXCL10 induces tamoxifen resistance in breast cancer [336] and therefore any interference with the expression of the aforementioned chemokine during therapy should be performed after careful examination of its interaction with other anticancer drugs. This evidence concerns the gene CXCL10 and breast cancer.